Lgnd stock price today

Nov 08, 2019 · Ligand Pharmaceuticals Inc. analyst estimates by MarketWatch. View LGND revenue estimates and earnings estimates, as well as analyst recommendations. LGND Stock Price Quote & News - Ligand Pharmaceuticals ... View the real-time LGND price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Ligand Pharmaceuticals against related stocks people have also bought like ABMD, GILD, VKTX, and BIDU. 864 people own Ligand Pharmaceuticals on … Ligand Pharmaceuticals Incorpor (LGND) Latest Stock News ...

LGND Stock Summary. With a price/earnings ratio of 2.7, Ligand Pharmaceuticals Inc P/E ratio is greater than that of about merely 1.93% of stocks in our set with positive earnings.

LGND Stock Quote of Ligand Pharm - InvestorPlace Check out our LGND stock analysis, current LGND quote, charts, and historical prices for Ligand Pharm stock We take a look at three biotech stocks whose … LGND -- Is Its Stock Price A Worthy Investment? Learn More. LGND Stock Summary. With a price/earnings ratio of 2.7, Ligand Pharmaceuticals Inc P/E ratio is greater than that of about merely 1.93% of stocks in our set with positive earnings. Does Wall Street Like Ligand Pharmaceuticals Inc. (LGND ... Wall Street is positive on Ligand Pharmaceuticals Inc. (LGND). On average, analysts give the stock a Strong Buy rating. The average price target is $171, which means analysts expect the stock to climb by 84.17% over the next twelve months. That rating i Ligand Pharmaceuticals Incorpor (LGND) stock price, quote ...

Stockopedia rates Ligand Pharmaceuticals Inc as a Balanced Style Neutral . Click to view NMQ:LGND's StockReport. StockRank™ Price to Book Value.

LGND -- Is Its Stock Price A Worthy Investment? Learn More. LGND Stock Summary. With a price/earnings ratio of 2.7, Ligand Pharmaceuticals Inc P/E ratio is greater than that of about merely 1.93% of stocks in our set with positive earnings. Does Wall Street Like Ligand Pharmaceuticals Inc. (LGND ... Wall Street is positive on Ligand Pharmaceuticals Inc. (LGND). On average, analysts give the stock a Strong Buy rating. The average price target is $171, which means analysts expect the stock to climb by 84.17% over the next twelve months. That rating i